A Systematic Review of Good Distribution Practices (GDP) Implementation Among Pharmaceutical Wholesalers in Indonesia
- DOI
- 10.2991/978-94-6239-762-0_19How to use a DOI?
- Keywords
- Good Distribution Practices; GDP; Pharmaceutical Wholesalers; Implementation; Pharmaceutical Distribution
- Abstract
- Background
Good Distribution Practices (GDP) are essential for maintaining the quality and safety of pharmaceutical products throughout the distribution chain. However, levels of compliance among pharmaceutical wholesalers (PBFs) in Indonesia vary considerably. Objectives: This review aims to evaluate the implementation of GDP across various Indonesian regions and identify key factors influencing compliance. Methods: A systematic review was conducted by the PRISMA 2020 guidelines. Literature was sourced from Google Scholar, ScienceDirect, and Europe PMC for articles published in Indonesian between 2017 and 2025. Inclusion criteria comprised original research evaluating GDP implementation in PBFs; review articles and inaccessible full texts were excluded. Results: Ten studies were included. Compliance with GDP standards showed significant regional variation. High compliance rates were observed in Batam, Tasikmalaya, and Jambi, at 99%, whereas Bandung and Jakarta had notably low rates of 5%. Common challenges included deficiencies in infrastructure, quality management, and personnel training. Regions with regular training and robust quality systems demonstrated better adherence. Conclusion: The implementation of GDP among Indonesian pharmaceutical wholesalers remains inconsistent, with substantial disparities across regions. Targeted interventions to strengthen infrastructure, documentation, and human resource development are necessary to enhance compliance and ensure safe pharmaceutical distribution nationwide.
- Copyright
- © 2026 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits any noncommercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if you modified the licensed material. You do not have permission under this license to share adapted material derived from this chapter or parts of it.
Cite this article
TY - CONF AU - Shela Febrina AU - Satibi Satibi AU - Susi Ari Kristina PY - 2026 DA - 2026/09/04 TI - A Systematic Review of Good Distribution Practices (GDP) Implementation Among Pharmaceutical Wholesalers in Indonesia BT - Proceedings of the 6th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BIOMIC 2025) PB - Atlantis Press SP - 287 EP - 302 SN - 2468-5739 UR - https://doi.org/10.2991/978-94-6239-762-0_19 DO - 10.2991/978-94-6239-762-0_19 ID - Febrina2026 ER -